| |
Anergy |
|
 |
Anergy Skin Testing
and Preventive Therapy for HIV-Infected Persons: Revised
Recommendations. - MMWR 1997; 46 (No. RR-15)
www.cdc.gov/mmwr/preview/mmwrhtml/00049386.htm
|
PDF |
| |
ATS
/ CDC Guidelines |
|
 |
Treatment of Tuberculosis MMWR 2003; 52 (No.
RR-11) www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
|
PDF |
| |
» Errata: Treatment of Tuberculosis
- MMWR 2005; 52 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5351a5.htm
|
PDF |
 |
Targeted Tuberculin
Testing and Treatment of Latent Tuberculosis Infection - MMWR
2000; 49 (No. RR-6)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm
|
PDF |
 |
Diagnostic
Standards / Classification of TB in Adults and Children
- Am J Respir Crit Care Med 2000; 161 |
PDF |
 |
Treatment
of Tuberculosis and Tuberculosis Infection - Am J Respir
Crit Care Med 1994; 149
|
PDF |
 |
Control
of Tuberculosis in the U.S. - Am Rev Respir Dis 1992;
146 |
PDF |
| |
BCG |
|
 |
The Role of BCG Vaccine
in the Prevention and Control of Tuberculosis in the United
States. (ACET and ACIP) - MMWR 1996; 45 (No. RR-4)
www.cdc.gov/mmwr/preview/mmwrhtml/00041047.htm
|
PDF |
| |
Control
and Elimination |
|
 |
Progressing Toward Tuberculosis
Elimination in Low-Incidence Areas of the United States -
MMWR 2002; 51 (No. RR-5) www.cdc.gov/mmwr/preview/mmwrhtml/rr5105a1.htm
|
PDF |
 |
Tuberculosis Elimination
Revisited: Obstacles, Opportunities, and a Renewed Commitment
(ACET).- MMWR 1999; 48 (No. RR-9)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4809a1.htm
|
PDF |
 |
Essential Components
of a Tuberculosis Prevention and Control Program (ACET)
- MMWR 1995; 44 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00038823.htm
|
PDF |
 |
Prevention and
Control of Tuberculosis in U.S. Communities with At-Risk
Minority Populations (ACET)- MMWR 1992; 41 (No.
RR-5)
www.cdc.gov/mmwr/preview/mmwrhtml/00019899.htm
|
PDF |
 |
Control
of Tuberculosis in the U.S. - Am Rev Respir Dis 1992; 146
|
PDF |
 |
A Strategic Plan for the Elimination
of Tuberculosis in the United States - MMWR
1989; 38 (S-3)
http://www.cdc.gov/mmwr/preview/mmwrhtml/00001375.htm
|
|
| |
Correctional
Facilities |
|
 |
Prevention and Control
of Tuberculosis in Correctional Facilities. (ACET) - MMWR
1996; 45 (No. RR-8)
www.cdc.gov/mmwr/preview/mmwrhtml/00042214.htm
|
PDF |
| |
Diagnosis |
|
 |
Diagnostic Standards
/ Classification of TB in Adults and Children - Am J Respir
Crit Care Med 2000; 161 |
PDF |
 |
Diagnostic Standards
/ Classification of TB - Am Rev Respir Dis 1990; Volume 142
(3) |
PDF |
| |
Elderly |
|
 |
Prevention and Control
of Tuberculosis in Facilities Providing Long-Term Care to
the Elderly - MMWR 1990; 39 (No. RR-10) www.cdc.gov/mmwr/preview/mmwrhtml/00001711.htm
|
PDF |
| |
Foreign-Born |
|
 |
Recommendations for
Prevention and Control of Tuberculosis among Foreign-Born
Persons - MMWR 1998; 47 (No. RR-16)
www.cdc.gov/mmwr/preview/mmwrhtml/00054855.htm
|
PDF |
| |
High-Risk
Settings |
|
 |
Prevention and
Control of Tuberculosis in Correctional Facilities (ACET)-
MMWR 1996; 45 (No. RR-8)
www.cdc.gov/mmwr/preview/mmwrhtml/00042214.htm
|
PDF |
 |
Screening for
Tuberculosis and Tuberculosis Infection in High-Risk Populations
(ACET)- MMWR 1995;44 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00038873.htm
|
PDF |
 |
Prevention and
Control of Tuberculosis Among Homeless Persons (ACET) -
MMWR 1992; 41 (No. RR-5)
www.cdc.gov/mmwr/preview/mmwrhtml/00019922.htm |
PDF |
 |
Prevention and
Control of Tuberculosis in Migrant Farm Workers (ACET) -
MMWR 1992; 41 (No. RR-10)
www.cdc.gov/mmwr/preview/mmwrhtml/00032773.htm |
PDF |
 |
Prevention and Control
of Tuberculosis in Facilities Providing Long-Term Care to
the Elderly (ACET) - MMWR 1990; 39 (RR-10) www.cdc.gov/mmwr/preview/mmwrhtml/00001711.htm
|
PDF |
| |
HIV
/ AIDS |
|
 |
Treating Opportunistic Infections Among
HIV-Infected Adults and Adolescents - MMWR 2004; 53 (RR15)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm
|
|
 |
Treating Opportunistic Infections
Among HIV-Exposed and Infected Children - MMWR 2004; 53
(RR14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm
|
|
 |
Notice to Readers: Updated Guidelines
for the Use of Rifamycins for the Treatment of Tuberculosis
Among HIV-Infected Patients Taking Protease Inhibitors or
Nonnucleoside Reverse Transcriptase Inhibitors - MMWR
2004; 53 (No. 2) www.cdc.gov/mmwr/preview/mmwrhtml/mm5302a6.htm
|
PDF |
 |
Updated
Guidelines for the Use of Rifamycins for the Treatment of
Tuberculosis Among HIV-Infected Patients Taking Protease
Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
|
PDF |
 |
Guidelines for Preventing Opportunistic
Infections Among HIV-Infected Persons --- 2002 - MMWR 2002;
51 (No. RR-8) www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm
|
PDF |
 |
Updated Guidelines
for the Use of Rifabutin or Rifampin for the Treatment and
Prevention of Tuberculosis Among HIV-Infected Patients Taking
Protease Inhibitors or Nonnucleoside Reverse Transcriptase
Inhibitors - MMWR 2000; 49 (No. 9)
www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm
|
PDF |
 |
Prevention and
Treatment of Tuberculosis among Patients Infected with Human
Immunodeficiency Virus: Principles of Therapy and Revised
Recommendations - MMWR 1998; 47 (No. RR-20)
www.cdc.gov/mmwr/preview/mmwrhtml/00055357.htm
|
PDF |
| |
Homeless |
|
 |
Prevention and
Control of Tuberculosis Among Homeless Persons (ACET) -
MMWR 1992; 41 (No. RR-5)
www.cdc.gov/mmwr/preview/mmwrhtml/00019922.htm
|
PDF |
| |
Infection
Control |
|
 |
Guidelines for Environmental Infection
Control in Health-Care Facilities - MMWR 2003; 52 (No. RR-10)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5210a1.htm
|
PDF |
 |
Guidelines for
Preventing the transmission of Mycobacterium tuberculosis
in Health-Care Facilities, 1994. - MMWR 1994; 43 (No.
RR-13)
www.cdc.gov/mmwr/preview/mmwrhtml/00035909.htm
|
PDF |
| |
Laboratory |
|
 |
|
PDF |
 |
New CDC Program for Rapid Genotyping of Mycobacterium
tuberculosis Isolates - MMWR 2005; 54 (No. 02) www.cdc.gov/mmwr/preview/mmwrhtml/mm5402a6.htm |
PDF |
 |
Guide
to the Application of Genotyping to Tuberculosis Prevention
and Control |
PDF |
| |
Laws |
|
 |
Tuberculosis Control
Laws - United States, 1993 (ACET) - MMWR 1993; 42
(No. RR-15)
www.cdc.gov/mmwr/preview/mmwrhtml/00030715.htm
|
PDF |
| |
Migrant
Farm Workers |
|
 |
Prevention and
Control of Tuberculosis in Migrant Farm Workers (ACET) -
MMWR 1992; 41 (No. RR-10)
www.cdc.gov/mmwr/preview/mmwrhtml/00032773.htm
|
PDF |
| |
Multidrug-Resistant
TB |
|
 |
National Action
Plan to Combat Multidrug-Resistant Tuberculosis. -
MMWR 1992; 41 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00031159.htm |
PDF |
 |
Management of
Persons Exposed to Multidrug-Resistant Tuberculosis.
- MMWR 1992; 41 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00031296.htm
|
PDF |
| |
Testing |
|
 |
Tuberculosis Associated with Blocking
Agents Against Tumor Necrosis Factor - Alpha - California,
2002–2003 - MMWR 2004; 53 (No. 30) www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a4.htm
|
PDF |
 |
Timing of Tuberculosis Screening and Smallpox
Vaccination - Recommendations for Using Smallpox Vaccine in
a Pre-Event Vaccination Program - MMWR 2003; 52 (No. RR-7)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5207a1.htm
|
PDF |
 |
Guidelines for Using the QuantiFERON-TB Test
for Diagnosing Latent Mycobacterium tuberculosis Infection.
MMWR 2003:52(RR-2); 15-18
www.cdc.gov/mmwr/preview/mmwrhtml/rr5202a2.htm |
PDF |
 |
Targeted Tuberculin
Testing and Treatment of Latent Tuberculosis Infection - MMWR
2000; 49 (No. RR-6)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm
|
PDF |
 |
Screening for
Tuberculosis and Tuberculosis Infection in High-Risk Populations
(ACET) - MMWR 1995; 44 (No. RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00038873.htm
|
PDF |
| |
Travel |
|
 |
Health Information for International
Travel www.cdc.gov/travel/yb/index.htm
|
|
| |
Treatment |
|
 |
Treating Opportunistic Infections Among
HIV-Infected Adults and Adolescents - MMWR 2004; 53 (RR15)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm
|
|
 |
Treating Opportunistic Infections
Among HIV-Exposed and Infected Children - MMWR 2004; 53
(RR14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm
|
|
 |
Updated
Guidelines for the Use of Rifamycins for the Treatment of
Tuberculosis Among HIV-Infected Patients Taking Protease
Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
|
PDF |
 |
Update: Adverse Event Data and Revised American
Thoracic Society/CDC Recommendations Against the Use of Rifampin
and Pyrazinamide for Treatment of Latent Tuberculosis Infection
MMWR 2003; 52 (No. 31). www.cdc.gov/mmwr/preview/mmwrhtml/mm5231a4.htm
|
PDF |
 |
Treatment of Tuberculosis MMWR 2003; 52 (No.
RR-11) www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
|
PDF |
| |
» Errata: Treatment of Tuberculosis
- MMWR 2005; 52 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5351a5.htm
|
PDF |
 |
Public Health Dispatch: Update: Fatal and Severe
Liver Injuries Associated with Rifampin and Pyrazinamide Treatment
for Latent Tuberculosis Infection - MMWR 2002; 51 (No. 44)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a4.htm
|
PDF |
 |
Targeted Tuberculin
Testing and Treatment of Latent Tuberculosis Infection -
MMWR 2000; 49 (No. RR-6)
www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm
|
PDF |
 |
Updated Guidelines
for the Use of Rifabutin or Rifampin for the Treatment and
Prevention of Tuberculosis Among HIV-Infected Patients Taking
Protease Inhibitors or Nonnucleoside Reverse Transcriptase
Inhibitors - MMWR 2000; 49 (No. 9)
www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm
|
PDF |
 |
Treatment of Tuberculosis
and Tuberculosis Infection - Am J Respir Crit
Care Med 1994; 149 |
PDF |
 |
Management of
Persons Exposed to Multidrug-Resistant Tuberculosis.
- MMWR 1992; 41 (RR-11)
www.cdc.gov/mmwr/preview/mmwrhtml/00031296.htm
|
PDF |
| |
Vaccines |
|
 |
General Recommendations on Immunization:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP) and the American Academy of Family Physicians
(AAFP). - MMWR 2002; 51 (No. RR-2).
www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm
|
PDF |
 |
Development of
new Vaccines for Tuberculosis. - MMWR 1998;
47 (No. RR-13)
www.cdc.gov/mmwr/preview/mmwrhtml/00054407.htm
|
PDF |
 |
The Role of BCG
Vaccine in the Prevention and Control of Tuberculosis in
the United States. (ACET and ACIP) - MMWR 1996;
45 (RR-4)
www.cdc.gov/mmwr/preview/mmwrhtml/00041047.htm
|
PDF |